Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
暂无分享,去创建一个
Roberto Molinaro | Manuela Sushnitha | Ennio Tasciotti | Michael Evangelopoulos | E. Tasciotti | Jonathan O. Martinez | M. Evangelopoulos | N. Arrighetti | A. Parodi | R. Molinaro | C. Corbo | Alessandro Parodi | Jonathan O Martinez | Claudia Corbo | Noemi Arrighetti | Manuela Sushnitha
[1] T. V. van Berkel,et al. P-selectin as a candidate target in atherosclerosis. , 2003, Biochemical pharmacology.
[2] E. Tasciotti,et al. Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.
[3] Anne L. van de Ven,et al. Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.
[4] Jingxia Cui,et al. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase , 2008 .
[5] M. Rybak,et al. A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.
[6] Stephen Mann,et al. Biomimetic Hydroxyapatite–Drug Nanocrystals as Potential Bone Substitutes with Antitumor Drug Delivery Properties , 2007 .
[7] Esther J Kim,et al. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages. , 2013, Biomaterials.
[8] R. Jain,et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.
[9] Dennis E. Discher,et al. Polymersomes as viral capsid mimics , 2006 .
[10] O. Garraud,et al. Emerging Evidence for Platelets as Immune and Inflammatory Effector Cells , 2014, Front. Immunol..
[11] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[12] I. K. Yazdi,et al. Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. , 2015, Nanomedicine.
[13] K. Burridge,et al. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. , 2001, Current opinion in cell biology.
[14] E. Tasciotti,et al. Bioinspired approaches for cancer nanotheranostics. , 2017, Nanomedicine.
[15] Y. Tabata,et al. Augmented liver targeting of exosomes by surface modification with cationized pullulan. , 2017, Acta biomaterialia.
[16] Shivani Singh,et al. Applications of Nanomaterials in Dental Science: A Review. , 2017, Journal of nanoscience and nanotechnology.
[17] Graça Raposo,et al. The Biogenesis and Functions of Exosomes , 2002, Traffic.
[18] Laurie J. Gay,et al. Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.
[19] Indu Pal Kaur,et al. Issues and concerns in nanotech product development and its commercialization. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[20] W. Tan,et al. Molecular Recognition-Based DNA Nanoassemblies on the Surfaces of Nanosized Exosomes. , 2017, Journal of the American Chemical Society.
[21] Rune Matthiesen,et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. , 2008, Journal of proteome research.
[22] R. Garcea,et al. Virus-like particles as vaccines and vessels for the delivery of small molecules. , 2004, Current opinion in biotechnology.
[23] Thomas J. Anchordoquy,et al. Surface Functionalization of Exosomes Using Click Chemistry , 2014, Bioconjugate chemistry.
[24] Jörg Huwyler,et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[25] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[26] Francesco Salvatore,et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.
[27] Inflammation in neurological and psychiatric diseases , 2012, Inflammopharmacology.
[28] Morteza Mahmoudi,et al. Personalized protein corona on nanoparticles and its clinical implications. , 2017, Biomaterials science.
[29] David V Schaffer,et al. Viral Vectors for Gene Therapy: Translational and Clinical Outlook. , 2015, Annual review of biomedical engineering.
[30] Gregory Y H Lip,et al. The adhesion molecule P-selectin and cardiovascular disease. , 2003, European heart journal.
[31] C. Théry,et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.
[32] Carmen Alvarez-Lorenzo,et al. Bioinspired drug delivery systems. , 2013, Current opinion in biotechnology.
[33] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[34] V. Weissig,et al. Nanopharmaceuticals (part 2): products in the pipeline , 2015, International journal of nanomedicine.
[35] C. Oliver,et al. Permeabilization of cell membranes. , 2010, Methods in molecular biology.
[36] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[37] I. K. Yazdi,et al. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA. , 2016, Biomaterials.
[38] N. Kieffer,et al. Platelet membrane glycoproteins: functions in cellular interactions. , 1990, Annual review of cell biology.
[39] Kathryn S Lilley,et al. Structural and functional characteristics of cGMP-dependent methionine oxidation in Arabidopsis thaliana proteins , 2013, Cell Communication and Signaling.
[40] Gregory P. Robbins,et al. Tunable leuko-polymersomes that adhere specifically to inflammatory markers. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[41] Bin He,et al. Smart nanovehicles based on pH-triggered disassembly of supramolecular peptide-amphiphiles for efficient intracellular drug delivery. , 2014, Small.
[42] Ronnie H. Fang,et al. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.
[43] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[44] M. Ferrari,et al. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability , 2016, Scientific Reports.
[45] Mauro Ferrari,et al. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications , 2012, Chinese science bulletin = Kexue tongbao.
[46] Liangfang Zhang,et al. Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.
[47] P. Kuo,et al. PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes. , 2016, Urology.
[48] C. Lagenaur,et al. Role of CD47 as a marker of self on red blood cells. , 2000, Science.
[49] H. Ishitobi,et al. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. , 2014, Biochemical and biophysical research communications.
[50] Brandon S. Brown,et al. Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.
[51] Yoshihiro Sasaki,et al. Engineering hybrid exosomes by membrane fusion with liposomes , 2016, Scientific Reports.
[52] R. Schiffelers,et al. Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.
[53] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[54] W. Liu,et al. Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. , 2015, Small.
[55] E. Trams,et al. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. , 1981, Biochimica et biophysica acta.
[56] Katsuhiko Ariga,et al. Bioinspired nanoarchitectonics as emerging drug delivery systems , 2014 .
[57] Ning Kang,et al. Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications. , 2015, Small.
[58] Kent Kirshenbaum,et al. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. , 2006, Nano letters.
[59] J. Zou,et al. Nanoparticles Mimicking Viral Surface Topography for Enhanced Cellular Delivery , 2013, Advanced materials.
[60] S. Lim,et al. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. , 2013, Biotechnology advances.
[61] Subinoy Rana,et al. Surface functionalization of nanoparticles for nanomedicine. , 2012, Chemical Society reviews.
[62] U. Sekhon,et al. Targeted killing of metastatic cells using a platelet- inspired drug delivery system , 2015 .
[63] Kinam Park,et al. Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.
[64] A. Nurden,et al. Specific roles for platelet surface glycoproteins in platelet function , 1975, Nature.
[65] J. Leroux,et al. Breakthrough discoveries in drug delivery technologies: the next 30 years. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[66] Michael J Monteiro,et al. An influenza virus-inspired polymer system for the timed release of siRNA , 2013, Nature Communications.
[67] M. Murata,et al. Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions. , 2002, Blood.
[68] Samir Mitragotri,et al. Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries , 2014, ACS nano.
[69] E. Elinav,et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.
[70] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[71] J. Degen,et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.
[72] M. Murthy,et al. Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles , 2016, Scientific Reports.
[73] Xin Hou,et al. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.
[74] S. Lippard,et al. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy. , 2016, ACS nano.
[75] M. Ferrari,et al. The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. , 2014, Biomaterials.
[76] Zhenjia Wang,et al. High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. , 2017, Biomaterials.
[77] Tracy K. Pettinger,et al. Nanopharmaceuticals (part 1): products on the market , 2014, International journal of nanomedicine.
[78] Mauro Ferrari,et al. Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System , 2011, Pharmaceutical Research.
[79] Ronnie H. Fang,et al. Nanoparticles disguised as red blood cells to evade the immune system , 2012, Expert opinion on biological therapy.
[80] J. Gostner,et al. Antioxidants, inflammation and cardiovascular disease. , 2014, World journal of cardiology.
[81] Dan Zhong,et al. Virus‐Inspired Mimics Based on Dendritic Lipopeptides for Efficient Tumor‐Specific Infection and Systemic Drug Delivery , 2015 .
[82] J. Freedman,et al. Platelets and the immune continuum , 2011, Nature Reviews Immunology.
[83] P. Bruhns,et al. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. , 2005, Blood.
[84] Ronnie H. Fang,et al. Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.
[85] R. Rodvien,et al. Role of platelets in hemostasis and thrombosis. , 1976, The Western journal of medicine.
[86] Ronnie H. Fang,et al. 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.
[87] M. Sherman,et al. Effects of the protein corona on liposome–liposome and liposome–cell interactions , 2016, International journal of nanomedicine.
[88] Albert Duschl,et al. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. , 2011, Small.
[89] M. Ferrari,et al. Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB. , 2017, ACS applied materials & interfaces.
[90] M. van Lookeren Campagne,et al. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. , 2008, Blood.
[91] M Kersaudy-Kerhoas,et al. Exosome isolation: a microfluidic road-map. , 2015, Lab on a chip.
[92] Wei Liu,et al. Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. , 2017, ACS nano.
[93] Samir Mitragotri,et al. Materials for Drug Delivery: Innovative Solutions to Address Complex Biological Hurdles , 2012, Advanced materials.
[94] Pengcheng Bu,et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. , 2016, Biomaterials.
[95] M. Sherman,et al. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers. , 2017, ACS nano.
[96] D. Rittenberg,et al. The life span of the human red blood cell. , 1946, The Journal of biological chemistry.
[97] M. Kinch,et al. An analysis of FDA-approved drugs for inflammation and autoimmune diseases. , 2015, Drug discovery today.
[98] Ronnie H. Fang,et al. Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.
[99] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[100] Meg Duroux,et al. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.
[101] M. Ferrari,et al. Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. , 2015, Current drug targets.
[102] F. Caruso,et al. Assembly of Layer-by-Layer Particles and Their Interactions with Biological Systems , 2014 .
[103] Timothy J. Foster,et al. The interaction of bacterial pathogens with platelets , 2006, Nature Reviews Microbiology.
[104] Joel C Sunshine,et al. Biomimetic particles as therapeutics. , 2015, Trends in biotechnology.
[105] D. Green,et al. Immunogenic and tolerogenic cell death , 2009, Nature Reviews Immunology.
[106] Imre Mäger,et al. Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.
[107] Jaesung Park,et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.
[108] Myung Soo Kim,et al. Using exosomes, naturally-equipped nanocarriers, for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[109] Dongin Kim,et al. A virus-mimetic nanogel vehicle. , 2008, Angewandte Chemie.
[110] Xuetao Cao,et al. Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells , 2006, European journal of immunology.
[111] Juliane Nguyen,et al. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[112] Ernst Wagner,et al. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. , 2012, Accounts of chemical research.
[113] Joseph S. Fernandez-Moure,et al. Nanoantibiotics: a new paradigm for the treatment of surgical infection. , 2017, Nanomedicine.
[114] Ronnie H. Fang,et al. Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors , 2016, Theranostics.
[115] D. J. Jerry,et al. Virus-inspired approach to nonviral gene delivery vehicles. , 2009, Biomacromolecules.
[116] Arunmozhiarasi Armugam,et al. microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model , 2013, PloS one.
[117] A. De Vita,et al. Biomimetic proteolipid vesicles for targeting inflamed tissues , 2016, Nature materials.
[118] Mark B. Carter,et al. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. , 2011, ACS nano.
[119] M. Agostini,et al. Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers , 2015, Nanomedicine.
[120] S. Raimondo,et al. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death , 2015 .
[121] Wolfgang Baumeister,et al. Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography , 2003, Science.
[122] Ronnie H. Fang,et al. A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.
[123] G. Ronquist,et al. Cardiomyocyte Microvesicles Contain DNA/RNA and Convey Biological Messages to Target Cells , 2012, PloS one.
[124] J. Le Pecq,et al. Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.
[125] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[126] Silvia Maria Doglia,et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[127] David T. Curiel,et al. Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.
[128] J W Smith,et al. Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[129] Tianbo Liu,et al. Viral-capsid-type vesicle-like structures assembled from M12L24 metal-organic hybrid nanocages. , 2011, Angewandte Chemie.
[130] Venkatareddy Nadithe,et al. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.
[131] Nelson Durán,et al. Advances in Dental Materials through Nanotechnology: Facts, Perspectives and Toxicological Aspects. , 2015, Trends in biotechnology.
[132] M. V. Filatov,et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro , 2013, Cell Communication and Signaling.
[133] Rong Ni,et al. Structural mimics of viruses through peptide/DNA co-assembly. , 2014, Journal of the American Chemical Society.
[134] Shiladitya Sengupta,et al. Clinical translational challenges in nanomedicine , 2014 .
[135] P. Sims,et al. Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. , 1989, The Journal of biological chemistry.
[136] E. Béraud,et al. Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells , 2012, PloS one.
[137] M. Lück,et al. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.
[138] R. Schiffelers,et al. Endothelial cells at inflammatory sites as target for therapeutic intervention. , 2002, Endothelium : journal of endothelial cell research.
[139] W. Zacharias,et al. Exosome isolation for proteomic analyses and RNA profiling. , 2011, Methods in molecular biology.
[140] F. A. Siddiqui,et al. Nanomedicine and drug delivery: a mini review , 2014, International Nano Letters.
[141] L. Medina-Kauwe,et al. Chemotherapy targeting by DNA capture in viral protein particles. , 2012, Nanomedicine.
[142] E. Tasciotti,et al. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. , 2015, Colloids and surfaces. B, Biointerfaces.
[143] R. Herzog,et al. Progress and prospects: immune responses to viral vectors , 2010, Gene Therapy.
[144] Stephen H. Hughes,et al. Protein delivery using engineered virus-like particles , 2011, Proceedings of the National Academy of Sciences.
[145] Jie Xue,et al. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. , 2007, Bioconjugate chemistry.
[146] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[147] F. Aqil,et al. Bovine milk-derived exosomes for drug delivery. , 2016, Cancer letters.
[148] Fabian Kiessling,et al. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. , 2013, Current opinion in biotechnology.
[149] Z. Gu,et al. Viral Mimicking Ternary Polyplexes: A Reduction‐Controlled Hierarchical Unpacking Vector for Gene Delivery , 2014, Advanced materials.
[150] Douglas Losordo,et al. Exosomes and cardiac repair after myocardial infarction. , 2014, Circulation research.
[151] V. Venditto,et al. Cancer nanomedicines: so many papers and so few drugs! , 2013, Advanced drug delivery reviews.
[152] J. Mu,et al. Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites. , 2015, Cancer research.
[153] Peter B Jahrling,et al. Exotic emerging viral diseases: progress and challenges , 2004, Nature Medicine.
[154] Luigi Biancone,et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.
[155] W. Mark Saltzman,et al. A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.
[156] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.